Techne Corporation(TECH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TECH Techne Corporation

交易中 03-23 14:59:44 EDT

52.49

+1.01

+1.96%

最高53.53	最低51.63	成交量91.72万
今开52.71	昨收51.48	日振幅3.69%
总市值81.79亿	流通市值81.32亿	总股本1.56亿
成交额4,800万	换手率0.59%	流通股本1.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TECH","market":"US","secType":"STK","nameCN":"Techne Corporation","latestPrice":52.49,"timestamp":1774292382287,"preClose":51.48,"halted":0,"volume":917164,"delay":0,"changeRate":0.01961926961926972,"floatShares":154934058,"shares":155812701,"eps":0.51926,"marketStatus":"交易中","change":1.01,"latestTime":"03-23 14:59:44 EDT","open":52.71,"high":53.53,"low":51.63,"amount":48002414.7865,"amplitude":0.036908,"askPrice":52.49,"askSize":111,"bidPrice":52.46,"bidSize":2,"shortable":3,"etf":0,"ttmEps":0.51926,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":51.48,"dividendRate":0.006096,"preHourTrading":{"tag":"盘前","latestPrice":52.77,"preClose":51.48,"latestTime":"09:29 EDT","volume":2737,"amount":143120.13856,"timestamp":1774272599999,"change":1.29,"changeRate":0.025058,"amplitude":0.051282},"postHourTrading":{"tag":"盘后","latestPrice":51.85,"preClose":51.48,"latestTime":"18:37 EDT","volume":238401,"amount":12273268.677325,"timestamp":1774046271434,"change":0.37,"changeRate":0.007187,"amplitude":0.007218},"volumeRatio":0.413477,"impliedVol":0.5112,"impliedVolPercentile":0.5458},"requestUrl":"/m/hq/s/TECH/wiki","defaultTab":"wiki","newsList":[{"id":"2620426814","title":"NEXION TECH(08420)发盈警 预期2025年公司权益持有人应占亏损大幅减少至不超过400万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620426814","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620426814?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:56","pubTimestamp":1773744995,"startTime":"0","endTime":"0","summary":"智通财经APP讯，NEXION TECH 公布，该集团预期于2025年取得公司权益持有人应占亏损大幅减少至不超过400万港元，2024年公司权益持有人应占亏损则为约1469.5万港元。该业绩改善主要是由于该业务分部收入由2024财年约1325.2万港元增加约1063.6万港元或80.3% 至2025财年约2388.8万港元; 软件即服务分部(已终止)的分部业绩亏损由2024财年约729.1万港元减少至2025财年不超过30万港元，此乃主要由于为减少持续亏损而削减经营活动，及已确认的无形资产减值亏损拨备减少至零。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414993.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08420","BK1134","IE0034390439.USD","BK4588","IE00B64QTZ34.USD","IE00B19Z6F94.USD","LU2237957811.SGD","BK4585","BK4121","TECH","LU2237957902.USD"],"gpt_icon":0},{"id":"1142929582","title":"Bio-Techne旗下Ella桌面免疫分析平台获欧盟CE-IVD认证 现已上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=1142929582","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142929582?lang=zh_cn&edition=full","pubTime":"2026-02-16 19:33","pubTimestamp":1771241600,"startTime":"0","endTime":"0","summary":"Bio-Techne公司宣布，其Ella桌面免疫分析平台已正式获得欧盟CE-IVD标志认证。这一重要里程碑意味着该平台现已获准在欧盟市场进行销售。Ella平台作为全自动化蛋白质生物标志物分析系统，能够实现样本到结果的全程自动化处理。此次获得CE-IVD认证，标志着该平台符合欧盟对体外诊断医疗设备的安全性与有效性要求，为欧洲医疗机构提供了更高效的免疫分析解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","TECH","BK4121","IE0034390439.USD","IE00B19Z6F94.USD","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"1123232804","title":"异动解读 | 季度业绩超预期，Techne Corporation盘中大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123232804","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123232804?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:05","pubTimestamp":1770217550,"startTime":"0","endTime":"0","summary":"生物技术公司Techne Corporation今日盘中大幅上涨5.14%，表现强劲。消息面上，公司公布了第二季度财报，其营收和利润均超出市场预期。业绩超预期主要得益于对其用于药物开发产品的强劲需求，特别是在大型制药公司这一最大终端市场，公司已连续第四个季度实现两位数增长。公司旗下的蛋白质科学部门销售额实现增长，而诊断和基因组学部门收入虽略有下降，但整体业绩仍展现出韧性。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TECH"],"gpt_icon":0},{"id":"1100810846","title":"Bio-Techne高管称公司美国学术业务小幅下滑，欧洲稳定增长部分抵消影响——电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1100810846","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100810846?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:13","pubTimestamp":1770214395,"startTime":"0","endTime":"0","summary":"在电话会议中，Bio-Techne公司高管指出，其美国学术业务出现了小幅度的下滑。然而，这一下降趋势被欧洲市场持续且稳定的增长部分抵消。整体来看，不同区域的市场表现呈现出一种此消彼长的态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z6F94.USD","IE00B64QTZ34.USD","TECH","BK4585","IE0034390439.USD","BK4588","BK4121"],"gpt_icon":0},{"id":"1148708265","title":"异动解读 | Techne Corporation盘前大涨5.04%，因季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1148708265","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148708265?lang=zh_cn&edition=full","pubTime":"2026-02-04 21:52","pubTimestamp":1770213178,"startTime":"0","endTime":"0","summary":"生物技术公司Techne Corporation（股票代码：TECH）今日盘前股价大幅上涨5.04%，表现强劲。消息面上，公司公布了第二季度财报，其营收和利润均超出市场预期。具体数据显示，第二季度营收达到约2.96亿美元，高于分析师预估的2.90亿美元；调整后每股利润为46美分，也超过了预期的43美分。业绩超预期主要得益于对其用于药物开发产品的强劲需求，特别是在大型制药公司这一最大终端市场，公司已连续第四个季度实现两位数增长。这一积极的财务表现显著提振了投资者信心，从而推动了股价在盘前交易时段的大幅上扬。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["TECH"],"gpt_icon":0},{"id":"1162136183","title":"Bio-Techne推出完全确定成分的合成替代品，扩展3D干细胞与类器官培养产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=1162136183","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162136183?lang=zh_cn&edition=full","pubTime":"2026-02-02 19:32","pubTimestamp":1770031934,"startTime":"0","endTime":"0","summary":"Bio-Techne公司近日宣布，其3D干细胞与类器官培养产品线迎来重要扩展，推出了一种全新的、完全确定成分的合成培养基替代方案。这一创新产品的推出，旨在为研究人员提供更稳定、更可重复的培养环境，从而推动干细胞生物学和类器官研究领域的进一步发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034390439.USD","IE00B64QTZ34.USD","BK4121","TECH","IE00B19Z6F94.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2593448135","title":"NEXION TECH(08420)拟出售SaaS业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2593448135","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593448135?lang=zh_cn&edition=full","pubTime":"2025-12-22 19:08","pubTimestamp":1766401682,"startTime":"0","endTime":"0","summary":"智通财经APP讯，NEXION TECH 公布，于2025年12月22日，该公司拟向Muhammad Ridzuan Gurbaksh Bin Abdullah出售Big Focus及Rich Joy的全部股权，总代价为50万港元，将以现金方式支付。据悉，巨确为一间于香港注册成立的有限公司及Big Focus 的全资附属公司，主要从事投资控股;及湖南渌江为一间于中国注册成立的公司及巨确的全资附属公司，主要于中国从事SaaS业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B64QTZ34.USD","IE0034390439.USD","BK4121","IE00B19Z6F94.USD","08420","BK4585","TECH","BK4588","BK1134"],"gpt_icon":0},{"id":"2593171305","title":"NEXION TECH(08420)股东将股票由摩根士丹利香港证券转入UBS Securities Hong Kong Limited 转仓市值344.28万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593171305","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593171305?lang=zh_cn&edition=full","pubTime":"2025-12-22 08:26","pubTimestamp":1766363178,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月19日，NEXION TECH(08420)股东将股票由摩根士丹利香港证券转入UBS Securities Hong Kong Limited，转仓市值344.28万港元，占比10.21%。NEXION TECH截至2025年6月30日止6个月中期业绩显示，该集团取得收益795.3万港元，同比增加14.5%；公司权益持有人应占亏损131.8万港元，同比减少63.07%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034390439.USD","IE00B64QTZ34.USD","BK4127","LU1989772840.SGD","LU2111349929.HKD","LU0098860793.USD","LU0314104364.USD","LU0912757837.SGD","LU2357305700.SGD","LU2347655156.SGD","BK1134","IE00BKVL7J92.USD","161027","LU0795875086.SGD","LU1363072403.SGD","BK4581","LU0158827781.USD","TECH","LU0557290698.USD","LU2089284900.SGD","BK4585","LU1244550577.SGD","LU0267386448.USD","LU0320765646.SGD","LU0795875169.SGD","LU1791710400.SGD","IE00BZ1G4Q59.USD","LU1162221912.USD","LU1548497426.USD","BK4121","BK4504","LU0106831901.USD","LU0971096721.USD","LU2133065610.SGD","LU0225283273.USD","IE00B19Z6F94.USD","LU0006306889.USD","LU1720051108.HKD","LU1732799900.SGD","LU2089283258.USD","08420","LU0106261372.USD","LU1244550494.USD","LU1791710582.SGD","LU2028103732.USD","LU0158827948.USD","BK4534","BK4588","LU2271345857.HKD"],"gpt_icon":0},{"id":"2591736236","title":"NEXION TECH(08420)股东将股票由中信里昂证券转入UBS Securities Hong Kong Limited 转仓市值566.11万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591736236","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591736236?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:16","pubTimestamp":1765844164,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，12月15日，NEXION TECH股东将股票由中信里昂证券转入UBS Securities Hong Kong Limited，转仓市值566.11万港元，占比17.71%。NEXION TECH截至2025年6月30日止6个月中期业绩显示，该集团取得收益795.3万港元，同比增加14.5%;公司权益持有人应占亏损131.8万港元，同比减少63.07%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IE0034390439.USD","08420","TECH","161027","IE00B19Z6F94.USD","BK1134","BK4585","BK4121","BK4588","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2586655532","title":"ECI TECH(08013)发布年度业绩，净利润263.8万港元，同比下降70.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586655532","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586655532?lang=zh_cn&edition=full","pubTime":"2025-11-26 23:09","pubTimestamp":1764169797,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ECI TECH(08013)发布截至2025年8月31日止年度业绩，收益1.95亿港元，同比下降2.6%;净利润263.8万港元，同比下降70.5%;每股基本盈利0.16港仙。期内收益减少乃主要由于年内全球经济状况恶化，导致安装项目减少。其他减少来自保安护卫服务减少，因所开展的保安护卫活动项目减少所致。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08013","TECH"],"gpt_icon":0},{"id":"1126731673","title":"Bio-Techne 第一季度调整后每股收益为0.42美元，低于IBES预期的0.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126731673","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126731673?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:41","pubTimestamp":1763570487,"startTime":"0","endTime":"0","summary":"11月5日——Bio-Techne第一季度净收入为3818.5万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z6F94.USD","TECH","IE0034390439.USD","BK4121","BK4585","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2584391671","title":"ECI TECH(08013)发盈警 预期年度取得除税后净利润同比减少不少于65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584391671","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584391671?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:37","pubTimestamp":1763541472,"startTime":"0","endTime":"0","summary":"智通财经APP讯，ECI TECH(08013)发布公告，预计本集团于报告年度(截至2025年8月31日止年度)的除税后净利润较截至2024年8月31日止年度减少不少于65%。董事会认为除税后净利润的减少主要乃由于为支持集团不断扩展的业务而聘请更多员工。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["TECH","08013"],"gpt_icon":0},{"id":"1103497009","title":"Techne Corporation：持续的生产力提升与成本控制措施促使第一季度调整后营业利润率达到29.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103497009","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103497009?lang=zh_cn&edition=full","pubTime":"2025-11-05 19:32","pubTimestamp":1762342347,"startTime":"0","endTime":"0","summary":"Techne Corporation：持续的生产力提升与成本控制措施促使第一季度调整后营业利润率达到29.9%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z6F94.USD","BK4121","TECH","BK4585","BK4588","IE0034390439.USD","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"1171789649","title":"Bio-Techne在Leica Biosystems的Bond Rx平台上推出Proximityscope™检测，以推进空间蛋白-蛋白相互作用研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1171789649","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171789649?lang=zh_cn&edition=full","pubTime":"2025-10-28 18:30","pubTimestamp":1761647412,"startTime":"0","endTime":"0","summary":"Bio-Techne在Leica Biosystems的Bond Rx平台上推出Proximityscope™检测，以推进空间蛋白-蛋白相互作用研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64QTZ34.USD","BK4121","IE00B19Z6F94.USD","TECH","BK4588","IE0034390439.USD","BK4585"],"gpt_icon":0},{"id":"1187502257","title":"Bio-Techne与Oxford Nanopore Technologies扩大合作协议，加速基因组合开发至2032年","url":"https://stock-news.laohu8.com/highlight/detail?id=1187502257","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187502257?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:19","pubTimestamp":1760008775,"startTime":"0","endTime":"0","summary":"Bio-Techne与Oxford Nanopore Technologies宣布扩大双方合作协议，旨在加速基因技术产品组合的开发进程，合作期限延续至2032年。此次协议扩展将为两家公司在基因领域的创新发展提供更广阔的合作空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64QTZ34.USD","ONT.UK","TECH","IE0034390439.USD","BK4585","IE00B19Z6F94.USD","BK5062","BK4121"],"gpt_icon":0},{"id":"2517602861","title":"花旗：维持Bio-Techne(TECH.US)评级，由中性调整至中性评级, 目标价由80.00美元调整至70.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517602861","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517602861?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:42","pubTimestamp":1741110163,"startTime":"0","endTime":"0","summary":"花旗：维持Bio-Techne(TECH.US)评级，由中性调整至中性评级, 目标价由80.00美元调整至70.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05014248524166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TECH"],"gpt_icon":0},{"id":"2514493324","title":"MINDTELL TECH(08611)发布年度业绩 净亏损114.8万马币 同比收窄78.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514493324","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514493324?lang=zh_cn&edition=full","pubTime":"2025-02-28 21:29","pubTimestamp":1740749342,"startTime":"0","endTime":"0","summary":"智通财经APP讯，MINDTELL TECH(08611)发布截至2024年11月30日止年度业绩，集团收益1424万马币，同比增长17.03%;净亏损114.8万马币，同比收窄78.86%;每股亏损0.29马币分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0034390439.USD","BK4121","IE00B19Z6F94.USD","BK1155","08611","BK4588","TECH","BK4585","IE00B64QTZ34.USD"],"gpt_icon":0},{"id":"2512172454","title":"Baird：下调Bio-Techne(TECH.US)评级，由优于大市调整至中性评级, 目标价由88.00美元调整至68.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512172454","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512172454?lang=zh_cn&edition=full","pubTime":"2025-02-19 18:21","pubTimestamp":1739960469,"startTime":"0","endTime":"0","summary":"Baird：下调Bio-Techne(TECH.US)评级，由优于大市调整至中性评级, 目标价由88.00美元调整至68.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19182148262971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TECH"],"gpt_icon":0},{"id":"2511569132","title":"MINDTELL TECH根据认购协议发行7800万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2511569132","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511569132?lang=zh_cn&edition=full","pubTime":"2025-02-13 12:44","pubTimestamp":1739421840,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　MINDTELL TECH（08611）发布公告，于2025年2月6日根据认购协议发行7800万股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-13/doc-inekieui1943154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","08611","IE00B64QTZ34.USD","BK4121","IE00B19Z6F94.USD","BK4585","IE0034390439.USD","BK1155","TECH"],"gpt_icon":0},{"id":"2511566224","title":"【MINDTELL TECH(08611.HK)根据认购协议发行7800万股】MINDTELL TECH(08611.HK)发布公告，于2025年2月6日根据认购协议发行7800万股。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511566224","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511566224?lang=zh_cn&edition=full","pubTime":"2025-02-13 12:26","pubTimestamp":1739420812,"startTime":"0","endTime":"0","summary":"MINDTELL TECH(08611.HK)发布公告，于2025年2月6日根据认购协议发行7800万股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13122648131456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE0034390439.USD","IE00B64QTZ34.USD","TECH","BK4585","08611","BK4588","IE00B19Z6F94.USD","BK1155","BK4121"],"gpt_icon":0}],"profile":{"websiteUrl":"http://investors.bio-techne.com","stockEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":-0.1323},{"period":"3month","weight":-0.1165},{"period":"6month","weight":-0.0314},{"period":"1year","weight":-0.1468},{"period":"ytd","weight":-0.1246}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Bio-Techne Corporation于1981年7月17日在明尼苏达州成立。Bio-Techne及其子公司共同经营业务，为全球的研究、诊断和生物处理市场开发、制造和销售生命科学试剂、仪器和服务。凭借其深厚的产品组合和应用专业知识，公司销售生物过程和分子诊断的科学调查的组成部分，揭示特定疾病的性质、诊断、病因和进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.486486,"avgChangeRate":-0.01276},{"month":2,"riseRate":0.540541,"avgChangeRate":0.021391},{"month":3,"riseRate":0.5,"avgChangeRate":0.008312},{"month":4,"riseRate":0.567568,"avgChangeRate":0.01994},{"month":5,"riseRate":0.567568,"avgChangeRate":0.050498},{"month":6,"riseRate":0.540541,"avgChangeRate":0.031978},{"month":7,"riseRate":0.567568,"avgChangeRate":0.019417},{"month":8,"riseRate":0.513514,"avgChangeRate":0.015323},{"month":9,"riseRate":0.459459,"avgChangeRate":0.007298},{"month":10,"riseRate":0.594595,"avgChangeRate":0.023203},{"month":11,"riseRate":0.621622,"avgChangeRate":0.024016},{"month":12,"riseRate":0.594595,"avgChangeRate":0.017892}],"exchange":"NASDAQ","name":"Techne Corporation","nameEN":"Bio-Techne"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Techne Corporation(TECH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Techne Corporation(TECH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Techne Corporation,TECH,Techne Corporation股票,Techne Corporation股票老虎,Techne Corporation股票老虎国际,Techne Corporation行情,Techne Corporation股票行情,Techne Corporation股价,Techne Corporation股市,Techne Corporation股票价格,Techne Corporation股票交易,Techne Corporation股票购买,Techne Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Techne Corporation(TECH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Techne Corporation(TECH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}